Skip to main content
. 2020 Sep 23;22:520–529. doi: 10.1016/j.omtn.2020.09.017

Figure 5.

Figure 5

The Expression of miR-122 and miR-30a Was Significantly Downregulated in the Sputum and Plasma of COPD Patients in the Exacerbation-Month12 Group

(A) The expression of miR-122 was notably inhibited in the sputum and plasma of COPD patients in the exacerbation-month12 group. (B) The expression of miR-30a was notably inhibited in the sputum and plasma of COPD patients in the exacerbation-month12 group.